Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01694875 · ClinicalTrials.gov registry record
Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System
A clinical trial, sponsored by Gen-Probe, Incorporated.
- Completed
- Registry status
- 2,200
- Enrollment target
NCT01694875: Completed study, sponsored by Gen-Probe, Incorporated.
NCT01694875 is a clinical trial that has completed, run by Gen-Probe, Incorporated. The registered enrollment target is 2,200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01694875 has completed, sponsored by Gen-Probe, Incorporated.
- COMPLETED
- Registry status
- 2,200 participants
- Enrollment target
Study Summary
The objective of the clinical study is to evaluate the AHPV-GT Assay using the PANTHER System in cervical cancer screening. This objective will be accomplished in the ASC-US Study by evaluating the performance characteristics of the AHPV-GT Assay using the PANTHER System in a sample population of women with ASC-US Pap test results who were 21 years of age or older ("≥21 years of age") at the time of their Pap visit. For the Adjunct Study, this objective will be accomplished by evaluating the ability of the AHPV-GT Assay using the PANTHER System to identify women at increased risk of cervical disease in a sample population of women with negative (NILM)cytology results who were ≥30 years of age at the time of their Pap visit.
Interventions
- DEVICE APTIMA HPV Assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,200 participants |
| Start Date | 2012-10 |
| Est. Completion | 2012-11 |
What the finished NCT01694875 record still lists
NCT01694875 is an observational study that tracks outcomes without assigning an intervention. Its 2,200 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which APTIMA HPV Assay is the first listed.
NCT01694875 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01694875 about?
NCT01694875 is a clinical study titled "Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System". The objective of the clinical study is to evaluate the AHPV-GT Assay using the PANTHER System in cervical cancer screening. This objective will be accomplished in the ASC-US Study by evaluating the performance characteristics of the AHPV-GT Assay using the PANTHER System in a sample population of w...
What is the current status of trial NCT01694875?
This trial is currently completed. The enrollment target is 2,200 participants. The study started on 2012-10. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01694875?
The interventions under investigation include: APTIMA HPV Assay (DEVICE).
Who is sponsoring clinical trial NCT01694875?
This trial is sponsored by Gen-Probe, Incorporated, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- NCT06682650 · 2,200 participants · NA
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia